XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary Shares
Ordinary Shares
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Unrealized Gain (Loss) on Derivative Instruments and Other
Foreign Currency Translation Adjustments
Total Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2019     517,000,000            
Beginning balance at Mar. 31, 2019 $ 2,972,000 $ 21,000 $ 6,136,000 $ (1,000) $ (3,012,000) $ 22,000 $ (42,000) $ (110,000) $ (152,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of Flex Ltd. ordinary shares at cost (in shares)     (16,000,000)            
Repurchase of Flex Ltd. ordinary shares at cost (173,000)   $ (173,000)            
Exercise of stock options 1,000   $ 1,000            
Issuance of Flex Ltd. vested shares under restricted share unit awards (in shares)     3,000,000            
Net income 39,000       39,000        
Stock-based compensation 53,000   $ 53,000            
Total other comprehensive income (loss) (14,000)           (3,000) (11,000) (14,000)
Ending balance (in shares) at Dec. 31, 2019     504,000,000            
Ending balance at Dec. 31, 2019 2,899,000   $ 6,016,000   (2,951,000)   (45,000) (121,000) (166,000)
Beginning balance (in shares) at Sep. 27, 2019     509,000,000            
Beginning balance at Sep. 27, 2019 2,806,000   $ 6,058,000   (3,062,000)   (59,000) (131,000) (190,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of Flex Ltd. ordinary shares at cost (in shares)     (5,000,000)            
Repurchase of Flex Ltd. ordinary shares at cost (61,000)   $ (61,000)            
Net income 111,000       111,000        
Stock-based compensation 19,000   $ 19,000            
Total other comprehensive income (loss) 24,000           14,000 10,000 24,000
Ending balance (in shares) at Dec. 31, 2019     504,000,000            
Ending balance at Dec. 31, 2019 $ 2,899,000   $ 6,016,000   (2,951,000)   (45,000) (121,000) (166,000)
Beginning balance (in shares) at Mar. 31, 2020 497,426,277   497,000,000            
Beginning balance at Mar. 31, 2020 $ 2,831,000   $ 5,948,000   (2,902,000)   (82,000) (133,000) (215,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of Flex Ltd. ordinary shares at cost (in shares)     (2,000,000)            
Repurchase of Flex Ltd. ordinary shares at cost (38,000)   $ (38,000)            
Issuance of Flex Ltd. vested shares under restricted share unit awards (in shares)     4,000,000            
Net income 373,000       373,000        
Stock-based compensation 62,000   $ 62,000            
Total other comprehensive income (loss) $ 153,000           66,000 87,000 153,000
Ending balance (in shares) at Dec. 31, 2020 498,971,803   499,000,000            
Ending balance at Dec. 31, 2020 $ 3,381,000   $ 5,972,000   (2,529,000)   (16,000) (46,000) (62,000)
Beginning balance (in shares) at Sep. 25, 2020     501,000,000            
Beginning balance at Sep. 25, 2020 3,115,000   $ 5,985,000   (2,737,000)   (45,000) (88,000) (133,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of Flex Ltd. ordinary shares at cost (in shares)     (2,000,000)            
Repurchase of Flex Ltd. ordinary shares at cost (38,000)   $ (38,000)            
Net income 208,000       208,000        
Stock-based compensation 25,000   $ 25,000            
Total other comprehensive income (loss) $ 71,000           29,000 42,000 71,000
Ending balance (in shares) at Dec. 31, 2020 498,971,803   499,000,000            
Ending balance at Dec. 31, 2020 $ 3,381,000   $ 5,972,000   $ (2,529,000)   $ (16,000) $ (46,000) $ (62,000)